Increased Sensitivity in Older Adults
Methotrexate, a chemotherapy and autoimmune disease medication, can have varying side effects depending on age. [1] For older adults, particularly those above 65, the body's ability to process and eliminate methotrexate may be impaired, leading to increased sensitivity to the medication. This can result in more severe side effects.
Higher Risk of Bone Marrow Suppression
Older patients taking methotrexate are at a higher risk of bone marrow suppression, which can lead to anemia, low white blood cell count, and bleeding. [2] This side effect is more likely in patients with pre-existing kidney or liver issues, as methotrexate is primarily eliminated through the kidneys.
Increased Risk of Neurological Side Effects
The older population may be more susceptible to neurological side effects, such as dizziness, confusion, and impaired cognitive function. [3] This can be due to decreased renal function and increased plasma levels of the medication.
Pre-existing Conditions Exacerbation
Age-related conditions, such as osteoporosis, may be exacerbated by methotrexate use, particularly with concurrent corticosteroid therapy. [4] Patients with a history of osteoporosis should be closely monitored, and alternative treatment options should be considered.
Patent Expiration Impact
As methotrexate patents expire (2023: US, pending for other countries), biosimilars and generic versions may become available, potentially altering the medication's age-related side effects profile due to differences in formulation and manufacturing. [5]
Consultation and Monitoring
To mitigate age-related side effects, healthcare providers should conduct thorough patient assessments, especially in older adults, before initiating methotrexate therapy. Regular monitoring of kidney and liver function, along with ongoing evaluation of side effects, is crucial to ensure safe and effective treatment.
Sources:
[1] DrugPatentWatch.com - Methotrexate patent information
[2] National Cancer Institute - Methotrexate
[3] European Medicines Agency - Methotrexate
[4] American College of Rheumatology - Methotrexate in Rheumatoid Arthritis
[5] IQVIA Institute for Human Data Science - Biosimilars and Generics